Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2017 Jul 19;17(12):e11–e25. doi: 10.1016/j.clml.2017.07.004

Figure 2.

Figure 2

Estimated 5-year Relative Survival Following Initiation of Second-Line Treatment in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patient Cohort (A) and Mayo Validation Cohort (B)